RAPS recognizes that the current situation in Ukraine impacts our members and customers on many levels. If you are directly impacted by the current situation in the region and are challenged to meet your deadlines or obligations to RAPS, please reach out to raps@raps.org so that we can defer those challenges. Your health and safety are paramount to us.

Regulatory Focus™ > News Articles > Quality & Compliance: Regulatory Challenges in Life Sciences Drive Evolution of Compliance-enabling

Quality & Compliance: Regulatory Challenges in Life Sciences Drive Evolution of Compliance-enabling Solutions

Posted 01 July 2010

With global health and regulatory authorities pushing for stricter disclosure and e-standards regulations, life sciences companies are increasingly challenged by compounded workloads, fragmented, paper-based processes and ineffective technology systems. As a result, most of these organizations lack the infrastructure to effectively operate and comply in a rapidly changing regulatory environment, resulting in costly product delays, regulatory fines and lost business opportunities.

 

© 2022 Regulatory Affairs Professionals Society.